MedPath

Bordetella pertussis serology in pregnancy.

Completed
Conditions
This study is to study prospectively the incidence of B.pertussis infection in pregnant women in the Groene Hart Hospital in Gouda, the Netherlands. Therefore bloodsamples will be taken from the mother at 12 weeks gestation, at delivery and 2 months after delivery. Also cord blood will be collected at delivery. In these blood samples IgG against pertussis toxin and IgA against whole cell B.pertussis will be measured (RIVM). Also the mothers will be asked to fill in questionaires.
Registration Number
NL-OMON26049
Lead Sponsor
/A
Brief Summary

F.G.A.Versteegh<br> thesis VUmc, Amsterdam 2005<br> Pertussis: new insights etc<br>

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
500
Inclusion Criteria

All pregnant women delivering at the department of gynecology and obstetrics of the Groene Hart Hospital.

Exclusion Criteria

N/A

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath